Greater synergism of retinoic acid receptor (RAR) agonists with vitamin D3 than that of retinoid X receptor (RXR) agonists with regard to growth inhibition and differentiation induction in monoblastic leukemia cells

Biochemical Pharmacology

Volumn 57, Issue 5, 1999, Pages 521-529

  Makishima, Makoto ^a   Shudo, Koichi ^b   Honma, Yoshio ^a  

^a SAITAMA CANCER CENTER   (Japan)

^b UNIVERSITY OF TOKYO   (Japan)

Author keywords

Differentiation; Leukemia; RAR; RXR; Vitamin D3

Indexed keywords

3,5 DI TERT BUTYL 4' CHALCONECARBOXYLIC ACID; 4 [(5,6,7,8 TETRAHYDRO 5,5,8,8 TETRAMETHYL 2 NAPHTHYL)CARBOXAMIDO]BENZOIC ACID; CD11B ANTIGEN; COLECALCIFEROL; NITROBLUE TETRAZOLIUM; RETINOIC ACID; RETINOIC ACID RECEPTOR; RETINOID; RETINOID X RECEPTOR; RO 41 5253; RO 47 5944; RO 48 2250; TAMIBAROTENE; UNCLASSIFIED DRUG;

ARTICLE; CELL DIFFERENTIATION; DRUG POTENTIATION; GROWTH INHIBITION; HUMAN; HUMAN CELL; LEUKEMIA CELL LINE; PRIORITY JOURNAL;

CELL DIFFERENTIATION; CELL DIVISION; CHOLECALCIFEROL; DRUG SYNERGISM; HUMANS; KINETICS; RECEPTORS, RETINOIC ACID; RETINOID X RECEPTORS; RETINOIDS; STRUCTURE-ACTIVITY RELATIONSHIP; TRANSCRIPTION FACTORS; TRETINOIN; U937 CELLS;

EID: 0033104220     PISSN: 00062952     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-2952(98)00329-3     Document Type: Article

References (40)

1. Degos L., Dombret H., Chomienne C., Daniel M.-T., Micléa J.-M., Chastang C., Castaigne S., Fenaux P. All-trans-retinoic acid as a differentiating agent in the treatment of acute promyelocytic leukemia. Blood. 85:1995;2643-2653.
2. Breitman T.R., Collins S.J., Keene B.R. Terminal differentiation of human promyelocytic leukemic cells in primary culture in response to retinoic acid Blood. 57:1981;1000-1004.
3. Honma Y., Fujita Y., Kasukabe T., Hozumi M., Sampi K., Sakurai M., Tsushima S., Nomura H. Induction of differentiation of human acute non-lymphocytic leukemia cells in primary culture by inducers of differentiation of human myeloid leukemia cell line HL-60. Eur J Cancer Clin Oncol. 19:1983;251-261.
4. Chomienne C., Ballerini P., Balitrand N., Daniel M.T., Fenaux P., Castaigne S., Degos L. All-trans retinoic acid in acute promyelocytic leukemias. II. In vitro studies: Structure-function relationship. Blood. 76:1990;1710-1717.
5. Gudas L.J. Retinoids and vertebrate development. J Biol Chem. 269:1994;15399-15402.
6. Kakizuka A., Miller W.H. Jr, Umesono K., Warrell R.P. Jr, Frankel S.R., Murty V.V.V.S., Dmitrovsky E., Evans R.M. Chromosomal translocation t(15;17) in human acute promyelocytic leukemia fuses RARα with a novel putative transcription factor, PML. Cell. 66:1991;663-674.
7. de Thé H., Lavau C., Marchio A., Chomienne C., Degos L., Dejean A. The PML-RARα fusion mRNA generated by the t(15;17) translocation in acute promyelocytic leukemia encodes a functionally altered RAR. Cell. 66:1991;675-684.
8. Sakashita A., Kizaki M., Pakkala S., Schiller S., Tsuruoka N., Tomosaki R., Cameron J.F., Dawson M.I., Koeffler H.P. 9-cis Retinoic acid Effects on normal and leukemic hematopoiesis in vitro . Blood. 81:1993;1009-1016.
9. Lee J.S., Newman R.A., Lippman S.M., Huber M.H., Minor T., Raber M.N., Krakoff I.H., Hong W.K. Phase I evaluation of all-trans-retinoic acid in adults with solid tumors. J Clin Invest. 11:1993;959-966.
10. Miller V.A., Rigas J.R., Benedetti F.M., Verret A.L., Tong W.P., Kris M.G., Gill G.M., Loewen G.R., Truglia J.A., Ulm E.H., Warrell R.P. Jr. Initial clinical trial of the retinoid receptor pan agonist 9-cis retinoic acid Clin Cancer Res. 2:1996;471-475.
11. 3 induces differentiation of human myeloid leukemia cells. Biochem Biophys Res Commun. 102:1981;937-943.
12. 3 being the most potent inducer. Leuk Res. 13:1989;609-614.
13. 3 prolong survival time of mice inoculated with myeloid leukemia cells. Proc Natl Acad Sci USA. 80:1983;201-204.
14. 3 for proliferation of leukemic transformation-free survival in myelodysplastic syndromes. Am J Hematol. 38:1991;67-68.
15. 3. In vivo and in vitro effects on human preleukemic and leukemic cells. Cancer Treat Rep. 69:1985;1399-1407.
16. Mangelsdorf D.J., Evans R.M. The RXR heterodimers and orphan receptors. Cell. 83:1995;841-850.
17. Fenaux P., Vanhaesbroucke C., Estienne M.H., Preud'Homme C., Pagniez D., Facon T., Millot F., Bauters F. Acute monocytic leukaemia in adults: Treatment and prognosis in 99 cases. Br J Haematol. 75:1990;41-48.
18. 3 on the differentiation of the human monocytic cell line U937. Leuk Res. 15:1991;1145-1152.
19. 3 for growth inhibition and differentiation induction of human myelomonocytic leukemia cells by tretinoin tocoferil, an α-tocopherol ester of all-trans retinoic acid Blood. 87:1996;3384-3394.
20. 3-induced monocytic differentiation of U937 cells. Leuk Res. 20:1996;665-676.
21. Defacque H., Sévilla C., Piquemal D., Rochette-Egly C., Marti J., Commes T. Potentiation of VD-induced monocytic leukemia cell differentiation by retinoids involves both RAR and RXR signaling pathways. Leukemia. 11:1997;221-227.
22. Hashimoto Y., Shudo K. Retinoids and their nuclear receptors. Cell Biol Rev. 25:1991;209-230.
23. Shudo K., Kagechika H. Structural evolution of retinoids. Adv Drug Res. 24:1983;81-119.
24. Umemiya H., Kagechika H., Fukasawa H., Kawachi E., Ebisawa M., Hashimoto Y., Eisenmann G., Erb C., Pornon A., Chambon P., Gronemeyer H., Shudo K. Action mechanism of retinoid-synergistic dibenzodiazepines. Biochem Biophys Res Commun. 233:1997;121-125.
25. Takuma T., Takeda K., Konno K. Synergism of tumor necrosis factor (TNF) and interferon-γ in induction of differentiation of human myeloblastic leukemic ML-1 cells. Biochem Biophys Res Commun. 145:1987;514-521.
26. 3 cooperatively inhibit proliferation and induce differentiation of human myeloid leukemia cells. Leuk Res. 20:1996;781-789.
27. Overton W.R. Modified histogram subtraction technique for analysis of flow cytometry data. Cytometry. 9:1988;619-626.
28. Kanatani Y., Kasukabe T., Okabe-Kado J., Hayashi S., Yamamoto-Yamaguchi Y., Motoyoshi K., Nagata N., Honma Y. Transforming growth factor β and dexamethasone cooperatively enhance c-jun gene expression and inhibit the growth of human monocytoid leukemia cells. Cell Growth Differ. 7:1996;187-196.
29. Berenbaum M.C. What is synergy? Pharmacol Rev. 41:1989;93-141.
30. 3 receptors. Cell. 65:1991;1255-1266.
31. Mangelsdorf D.J., Umesono K., Kliewer S.A., Borgmeyer U., Ong E.S., Evans R.M. A direct repeat in the cellular retinol-binding protein type II gene confers differential regulation by RXR and RAR. Cell. 66:1991;555-561.
32. 3 enhancement of mouse secreted phosphoprotein 1 (Spp-1 or osteopontin) gene expression. Proc Natl Acad Sci USA. 87:1990;9995-9999.
33. Apfel C.M., Kamber M., Klaus M., Mohr P., Keidel S., LeMotte P.K. Enhancement of HL-60 differentiation by a new class of retinoids with selective activity on retinoid X receptor. J Biol Chem. 270:1995;30765-30772.
34. Apfel C., Bauer F., Crettaz M., Forni L., Kamber M., Kaufmann F., LeMotte P., Pirson W., Klaus M. A retinoic acid receptor α antagonist selectively counteracts retinoic acid effects. Proc Natl Acad Sci USA. 89:1992;7129-7133.
35. Botling J., Öberg F., Törmä H., Tuohimaa P., Bläuer M., Nilsson K. Vitamin D3- and retinoic acid-induced monocytic differentiation: Interactions between the endogenous vitamin D3 receptor, retinoic acid receptors, and retinoid X receptors in U-937 cells. Cell Growth Differ. 7:1996;1239-1249.
36. 3 receptor- and retinoid X receptor-mediated gene activation in vivo. Mol Cell Biol. 16:1996;1006-1016.
37. Forman B.M., Umesono K., Chen J., Evans R.M. Unique response pathways are established by allosteric interactions among nuclear hormone receptors. Cell. 81:1995;541-550.
38. Tontonoz P., Nagy L., Alvarez J.G.A., Thomazy V.A., Evans R.M. PPARγ promotes monocyte/macrophage differentiation and uptake of oxidized LDL. Cell. 93:1998;241-252.
39. Tobita T., Takeshita A., Kitamura K., Ohnishi K., Yanagi M., Hiraoka A., Karasuno T., Takeuchi M., Miyawaki S., Ueda R., Naoe T., Ohno R. Treatment with a new synthetic retinoid, Am80, of acute promyelocytic leukemia relapsed from complete remission induced by all-trans retinoic acid Blood. 90:1997;967-973.
40. Miller V.A., Benedetti F.M., Rigas J.R., Verret A.L., Pfister D.G., Straus D., Kris M.G., Crisp M., Heyman R., Loewen G.R., Truglia J.A., Warrell R.P. Jr. Initial clinical trial of a selective retinoid X receptor ligand, LGD1069. J Clin Oncol. 15:1997;790-795.